Article
Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells.
Infection and immunity - 1 Jan 2003
Basu Indira, Ferens Witold A, Stone Diana M, Hovde Carolyn J
Abstract excerpt
This study expanded our earlier finding that Shiga toxin type 1 (Stx1) has activity against bovine leukemia virus (BLV) (W. A. Ferens and C. J. Hovde, Infect. Immun. 68:4462-4469, 2000). The Stx molecular motifs required for antiviral activity were identified, and a mechanism of Stx action on virally infected cells is suggested. Using inhibition of BLV-dependent spontaneous lymphocyte proliferation as a measure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
